These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9041661)

  • 21. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
    Probert WS; Crawford M; Cadiz RB; LeFebvre RB
    J Infect Dis; 1997 Feb; 175(2):400-5. PubMed ID: 9203661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
    Benach JL
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.
    Telford SR; Fikrig E; Barthold SW; Brunet LR; Spielman A; Flavell RA
    J Exp Med; 1993 Aug; 178(2):755-8. PubMed ID: 8340764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant outer surface protein a from Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice.
    Simon MM; Schaible UE; Kramer MD; Eckerskorn C; Museteanu C; Müller-Hermelink HK; Wallich R
    J Infect Dis; 1991 Jul; 164(1):123-32. PubMed ID: 1829104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
    Cinco M; Trevisan G; Agolzer A
    Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.
    Ulbrandt ND; Cassatt DR; Patel NK; Roberts WC; Bachy CM; Fazenbaker CA; Hanson MS
    Infect Immun; 2001 Aug; 69(8):4799-807. PubMed ID: 11447153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complement-killing of Borrelia burgdorferi. Target antigens and sensitizing antibodies.
    Cacciapuoti B; Ciarrocchi S; Ciceroni L
    Zentralbl Bakteriol; 1998 Jul; 288(1):121-9. PubMed ID: 9728412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.
    Hanson MS; Cassatt DR; Guo BP; Patel NK; McCarthy MP; Dorward DW; Höök M
    Infect Immun; 1998 May; 66(5):2143-53. PubMed ID: 9573101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recombinant vaccine for Lyme disease.
    Wallich R; Kramer MD; Simon MM
    Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
    Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ
    J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.
    Bockenstedt LK; Fikrig E; Barthold SW; Kantor FS; Flavell RA
    J Immunol; 1993 Jul; 151(2):900-6. PubMed ID: 8335917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach to a Lyme disease vaccine.
    Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
    Yang X; Li Y; Dunn JJ; Luft BJ
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis of an outer surface protein from the Lyme disease spirochete, Borrelia burgdorferi, using circular dichroism and fluorescence spectroscopy.
    France LL; Kieleczawa J; Dunn JJ; Hind G; Sutherland JC
    Biochim Biophys Acta; 1992 Mar; 1120(1):59-68. PubMed ID: 1554741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment.
    Li H; Lawson CL
    J Struct Biol; 1995; 115(3):335-7. PubMed ID: 8573475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
    Liang FT; Caimano MJ; Radolf JD; Fikrig E
    Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.
    Fikrig E; Tao H; Chen M; Barthold SW; Flavell RA
    J Clin Invest; 1995 Oct; 96(4):1706-14. PubMed ID: 7560061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
    Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
    FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-terminal invariable domain of VlsE may not serve as target for protective immune response against Borrelia burgdorferi.
    Liang FT; Jacobs MB; Philipp MT
    Infect Immun; 2001 Mar; 69(3):1337-43. PubMed ID: 11179296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.